Skip to main content
TipRanks
Go Ultimate75% OFF

Malcolm Taub Insider Profile

4 Followers

Malcolm Taub, Director at Brainstorm Cell Therapeutics, holds 77.33K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).

Malcolm Taub's Trading History

BCLI
Brainstorm Cell Therapeutics
Dec 17, 2021DirectorUninformative Buy―$76.56K
BCLI
Insider Shares: 77.33K (0.21%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 17, 2021Uninformative Buy$0.0012,000$0.00―
Dec 10, 2021Uninformative Buy$0.0012,000$0.00―
Feb 14, 2020Uninformative Buy$0.0012,000$0.00―
Nov 30, 2018Uninformative Buy$0.0012,000$0.00―
Nov 13, 2017Uninformative Buy$0.0012,000$0.00―

You May Also Like

Malcolm Taub insider profile FAQ

What is the percentage of profitable transactions made by Malcolm Taub?
The percentage of profitable transactions made by Malcolm Taub is 50%.
What is the average return per transaction made by Malcolm Taub?
The average return per transaction made by Malcolm Taub is 1.00%.
What stocks does Malcolm Taub hold?
Malcolm Taub holds: BCLI stocks.
What was Malcolm Taub's most profitable transaction?
Malcolm Taub’s most profitable transaction was an Informative Sell of BCLI stock on December 16, 2015. The return on the trade was 3.20%.
What is Malcolm Taub's role in Brainstorm Cell Therapeutics?
Malcolm Taub's role in Brainstorm Cell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.